Sign in
4/A

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001799191-22-000060

Director acquired 65,174 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
BARASCH RICHARD A Director 2022-11-17 Grant or award +65,174 207,193 D: show line 1 in the form
Loading xslF345X03/edgardoc.xml…